Brain MRI findings in patients with bullous pemphigoid: A case–control study. Issue 4 (29th January 2023)

• Record Type: Journal Article
• Authors: Ganji, Raziyeh; Mahboubi‐Fooladi, Zahra; Shahidi‐Dadras, Mohammad; Tehranchinia, Zohreh; Abdollahimajd, Fahimeh; Ghalamkarpour, Fariba; Robati, RM; Gheisari, Mehdi; Mozafari, Nikoo; Dadkhahfar, Sahar; Nasiri, Soheila
• Is Part Of: Experimental dermatology. Volume 32:Issue 4(2023)
• Page Start: 542
• Page End: 546
• Publication Date: 2023-01-29
• Subjects: brain MRI -- bullous pemphigoid -- neurological disorders; Dermatology -- Periodicals; 616.5
• DOI: 10.1111/exd.14748
• Languages: English
• ISSNs: 0906-6705

Abstract

Abstract: Evidence suggests that bullous pemphigoid (BP) is associated with multiple neurological disorders. We aimed to compare brain magnetic resonance (MRI) findings between BP patients and a control group. This case–control study included patients with BP referred to two dermatology clinics during a two‐year period. A group of individuals attending the same clinics for cosmetic procedures were selected as controls. First, participants' general information including age, gender, education, weight and underlying disease was recorded. For BP patients, the drugs and the BP Disease Area Index (BPDAI) were recorded as well. Then, all participants underwent brain MRI without contrast. The Fazekas scale, the general cerebral atrophy (GCA) score, and the Medial Temporal lobe Atrophy (MTA) score were used to assess MRI images. Overall, 24 BP patients and 24 controls were evaluated in this study. Both groups were comparable regarding age, gender and education. However, diabetes and hypertension were more frequent in the control group. The mean BPDAI total score was 51.39 ± 68.92 in BP patients and most of them used rituximab (41.7%). None of the participants had MS or Alzheimer MRI patterns. There was no difference between groups in terms of GCA and MTA scores. Furthermore, the frequency of partially empty sella did not differ significantly between BP patients and controls ( p = 0.461); nevertheless, grade‐3 Fazekas was significantly higher in BP patients compared to controls (25% vs. 0%, p = 0.019). Of note, one BP patient had an epidermoid cyst and another had moderate enlargement of three ventricles. Also, new infarcts were observed in two and old infarcts in four BP patients. Although the majority of abnormal brain MRI findings were more frequent in BP patients compared to controls, only grade‐3 Fazekas was significantly higher and acute infarcts were exclusively observed in BP patients.